Join Our Newsletter

InMed Pharmaceuticals, Inc. - IMLFF

RSI %R Tweets Wolf Odds
71 -29 111 22.62%

Industry: Drug Manufacturers - Specialty & Generic / Sector: Healthcare



Prev Close: 0.779
Open: 0.7790
Last Trade: 0.7548
Change %: -3.110%
Change: -0.0242000
Volume: 1063587
Avg Vol: 903117
Relative Vol: 1.18
Day Range: 0.7495 -0.7948
52-Week Range: 0.090 - 0.720
Market Cap: 45.12M
Float: 112.83M
Shares Outstanding: N/A
Insider Owned: 0.00%
Institution Owned: 0.00%
Beta: 4.90
PE Ratio: 0.00
EPS: -0.041

IMLFF Detailed Stats

RSI:70.65 %K:71.36 Wolf Odds: 22.62% Tweets Today:111 SMA14:0.6544
stochRSI:0.80 %D:73.68 Wolf Trend:0.47 Tweet Avg:20 Pivot Price:0.7663667
%R:-28.64 %B:0.75 Wolf 3-Day:0.45 Avg. Change 3-Day:+0.057% Resistance 1:0.7832333
MFI:59.07 Bandwidth:0.604959 Wolf 7-Day:0.51 Avg. Change 7-Day:+2.881% Resistance 2:0.8116667
WolfPeak:0.65 Vortex Indicator:0.37 Wolf 14-Day:0.54 Avg. Change 14-Day:+2.12% Support 1:0.7379333
ROC 7/14:20.1337/40.0371 Aroon Oscillator:64.2857 EOM:0.050488 Relative Vol:1.18 Support 2:0.7210667
RSI Alert:None WolfPeak Alert:None Vortex Alert:None Aroon Alert:None EOM Alert:None

Featured News *


IMLFF Description

InMed Pharmaceuticals Inc., a pre-clinical stage biopharmaceutical company, engages in the research and development of novel and cannabinoid-based therapies in Canada. The company?s products under pre-clinical development stage include INM-750 for the treatment of epidermolysis bullosa; and INM-085 for the treatment of glaucoma. It is also developing various drugs for diseases, such as ocular, pain and inflammation, dermatology, central nervous system, metabolic, and respiratory. InMed Pharmaceuticals Inc. has an agreement with Pharmaseed Ltd to develop a final formulation for a topical cannabinoid product candidate intended as a therapy in epidermolysis bullosa (EB) and other dermatological and wound-healing applications; and a research and development collaboration agreement with ATERA SAS to develop 3D human skin models of EB, as well as to evaluate the in vitro drug efficacy of InMed?s lead compound, INM-750. The company was formerly known as Cannabis Technologies Inc. and changed its name to InMed Pharmaceuticals Inc. in October 2014. InMed Pharmaceuticals Inc. was incorporated in 1981 and is based in Vancouver, Canada.

IMLFF Comments

Recent IMLFF Tweets

Powered by Ekonomys ver. 9

StockWolf is dedicated to Penny Stock quotes and data to provide information, news, and education on penny stocks to help in your due diligence.

30min+ delay on data. All data is picked with automated algorithms and not vetted for accuracy. Please, read ALL information and disclaimers before using our service. StockWolf is not a licensed financial adviser, and not liable for your loses. Trade responsibly. This site is for education purposes only not a recommendation to buy/sell